Sylwia Chocholska (S Chocholska)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Venues

Cells

International journal of molecular sciences

Genes

Cancers

Medical University of Lublin

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical University of Lublin

Poland

Ph.D. :: Department of Haematooncology and Bone Marrow Transplantation

Publications

Szymon Zmorzyński, Sylwia Popek-Marciniec, Beata Biernacka, Aneta Szudy-Szczyrek, Sylwia Chocholska, Wojciech Styk, Joanna Czerwik-Marcinkowska, Grazyna Swiderska-Kolacz
In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Account the GSTT1 and GSTM1 Gene Variants. Genes 15 (3) (2024)
Szymon Zmorzyński, Sylwia Popek-Marciniec, Beata Biernacka, Aneta Szudy-Szczyrek, Sylwia Chocholska, Wojciech Styk, Joanna Czerwik-Marcinkowska, Grazyna Swiderska-Kolacz
In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Account the GSTT1 and GSTM1 Gene Variants. Genes 15 (3) (2024)
Szymon Zmorzyński, Sylwia Popek-Marciniec, Beata Biernacka, Aneta Szudy-Szczyrek, Sylwia Chocholska, Wojciech Styk, Joanna Czerwik-Marcinkowska, Grazyna Swiderska-Kolacz
In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Account the GSTT1 and GSTM1 Gene Variants. Genes 15 (3) (2024)
Szymon Zmorzyński, Sylwia Popek-Marciniec, Beata Biernacka, Aneta Szudy-Szczyrek, Sylwia Chocholska, Wojciech Styk, Joanna Czerwik-Marcinkowska, Grazyna Swiderska-Kolacz
In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Account the GSTT1 and GSTM1 Gene Variants. Genes 15 (3) (2024)
Justyna Woś, Agata Szymańska, Natalia Lehman, Sylwia Chocholska, Michał Konrad Zarobkiewicz, Piotr Pożarowski, Agnieszka A Bojarska-Junak
Can Galectin-3 Be a Novel Biomarker in Chronic Lymphocytic Leukemia? Cells 13 (1) (2023)
Justyna Woś, Agata Szymańska, Natalia Lehman, Sylwia Chocholska, Michał Konrad Zarobkiewicz, Piotr Pożarowski, Agnieszka A Bojarska-Junak
Can Galectin-3 Be a Novel Biomarker in Chronic Lymphocytic Leukemia? Cells 13 (1) (2023)
Justyna Woś, Agata Szymańska, Natalia Lehman, Sylwia Chocholska, Michał Konrad Zarobkiewicz, Piotr Pożarowski, Agnieszka A Bojarska-Junak
Can Galectin-3 Be a Novel Biomarker in Chronic Lymphocytic Leukemia? Cells 13 (1) (2023)
Sylwia Chocholska, Michał Konrad Zarobkiewicz, Agata Szymańska, Natalia Lehman, Justyna Woś, Agnieszka A Bojarska-Junak
Prognostic Value of the miR-17~92 Cluster in Chronic Lymphocytic Leukemia. International journal of molecular sciences 24 (2) (2023)
Sylwia Chocholska, Michał Konrad Zarobkiewicz, Agata Szymańska, Natalia Lehman, Justyna Woś, Agnieszka A Bojarska-Junak
Prognostic Value of the miR-17~92 Cluster in Chronic Lymphocytic Leukemia. International journal of molecular sciences 24 (2) (2023)
Justyna Woś, Agata Szymańska, Natalia Lehman, Sylwia Chocholska, Michał Konrad Zarobkiewicz, Piotr Pożarowski, Agnieszka A Bojarska-Junak
Can Galectin-3 Be a Novel Biomarker in Chronic Lymphocytic Leukemia? Cells 13 (1) (2023)
Sylwia Chocholska, Michał Konrad Zarobkiewicz, Agata Szymańska, Natalia Lehman, Justyna Woś, Agnieszka A Bojarska-Junak
Prognostic Value of the miR-17~92 Cluster in Chronic Lymphocytic Leukemia. International journal of molecular sciences 24 (2) (2023)
Sylwia Chocholska, Michał Konrad Zarobkiewicz, Agata Szymańska, Natalia Lehman, Justyna Woś, Agnieszka A Bojarska-Junak
Prognostic Value of the miR-17~92 Cluster in Chronic Lymphocytic Leukemia. International journal of molecular sciences 24 (2) (2023)
Justyna Woś, Agata Szymańska, Natalia Lehman, Sylwia Chocholska, Michał Konrad Zarobkiewicz, Piotr Pożarowski, Agnieszka A Bojarska-Junak
Can Galectin-3 Be a Novel Biomarker in Chronic Lymphocytic Leukemia? Cells 13 (1) (2023)
Sylwia Chocholska, Michał Konrad Zarobkiewicz, Agata Szymańska, Natalia Lehman, Justyna Woś, Agnieszka A Bojarska-Junak
Prognostic Value of the miR-17~92 Cluster in Chronic Lymphocytic Leukemia. International journal of molecular sciences 24 (2) (2023)
Agnieszka A Bojarska-Junak, Agnieszka Bojarska-Junak, Sylwia Chocholska, Agata Szymańska, Waldemar Tomczak, Michał Konrad Zarobkiewicz, Jacek Roliński
Prognostic Potential of Galectin-9 mRNA Expression in Chronic Lymphocytic Leukemia. Cancers 15 (22) (2023)
Aneta Szudy-Szczyrek, Radosław Mlak, Marcin Mazurek, Tomasz Krajka, Sylwia Chocholska, Paulina Bitkowska, Marta Jutrzenka, Michał Szczyrek, Iwona Homa-Mlak, Andrzej Krajka, Teresa Małecka-Massalska, Marek Hus
The TT Genotype of the KIAA1524 rs2278911 Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma. Cells 12 (7) (2023)
Szymon Zmorzyński, Sylwia Popek-Marciniec, Wojciech Styk, M Wojcierowska-Litwin, I Korszeń-Pilecka, Aneta Szudy-Szczyrek, Sylwia Chocholska, Marek Hus, Agata Anna Filip
The Impact of the NOD2/CARD15 Variant (3020insC) and PSMA6 Polymorphism (-8C>G) on the Development and Outcome of Multiple Myeloma. BioMed research international 2020 (2020)

Sylwia Chocholska.css-eqlu8i{font-size:small;padding-left:4px;} (S Chocholska)

Publication Activity (10 Years)

Top Topics

Top Venues

Sylwia Chocholska (S Chocholska)